Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 10626 - 10650 of 12370 in total

Abivertinib

Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. In binding to and inhibiting EGFR and BTK receptors,...
Investigational
Matched Iupac: … N-{3-[(2-{[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Cilazaprilat

Experimental
Matched Iupac: … (1S,9S)-9-{[(1S)-1-carboxy-3-phenylpropyl]amino}-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine- ... 1-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Patulin

Experimental
Matched Iupac: … 4-hydroxy-2H,4H,6H-furo[3,2-c]pyran-2-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Relmacabtagene autoleucel

Investigational

Demplatin pegraglumer

Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).
Investigational

Vanzacaftor

Investigational
Matched Iupac: … (14S)-8-[3-(2-{dispiro[2.0.2^{4}.1^{3}]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2lambda6-thia ... -3,9,11,18,23-pentaazatetracyclo[17.3.1.1^{11,14}.0^{5,10}]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4 …

Merestinib

Merestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.
Investigational
Matched Iupac: … N-(3-fluoro-4-{[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy}phenyl)-1-(4-fluorophenyl)-6-methyl- ... 2-oxo-1,2-dihydropyridine-3-carboxamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Troxipide

Experimental
Matched Iupac: … 3,4,5-trimethoxy-N-(piperidin-3-yl)benzamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Moroxydine

Experimental
Matched Iupac: … N-(morpholine-4-carboximidoyl)guanidine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Benzylthiouracil

Experimental
Matched Iupac: … 6-benzyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Pitofenone

Experimental
Matched Iupac: … methyl 2-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}benzoate …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

TAK-715

TAK-715 is under investigation in clinical trial NCT00760864 (Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis).
Investigational
Matched Iupac: … N-{4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl}benzamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Pipethanate

Experimental
Matched Iupac: … 2-(piperidin-1-yl)ethyl 2-hydroxy-2,2-diphenylacetate …
Matched Salts cas: … 4544-15-4 …

Inolimomab

Inolimomab is under investigation as an agent to treat steroid-resistant graft vs host disease. It has thus far offered similar efficacy to other monoclonal antibody options, though it may carry a higher risk of infections.
Investigational

2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin

Experimental
Matched Name: … 2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin …
Matched Iupac: … 6-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol ... (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3R,4R,5S)-4-{2-[(3-aminopropyl)amino]ethoxy}-5-{[(1R ... ,2R,3S,5R,6S)-3,5-diamino-2-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}- …

2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE

Experimental
Matched Name: … 2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE …
Matched Iupac: … N-[2-(3-benzoylphenoxy)ethyl]-N-hydroxyformamide …

(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE

Experimental
Matched Name: … (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE …
Matched Iupac: … (2S)-2-(butanoyloxy)-3-hydroxypropyl nonanoate …

N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE

Experimental
Matched Name: … N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE …
Matched Iupac: … methyl({[5-(pyridin-3-yl)furan-2-yl]methyl})amine …

Naluzotan

Investigational
Matched Iupac: … N-(3-{4-[4-(cyclohexylmethanesulfonamido)butyl]piperazin-1-yl}phenyl)acetamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Teneligliptin

Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.
Investigational
Matched Iupac: … 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-4-[(3S,5S)-5-(1,3-thiazolidine-3-carbonyl)pyrrolidin-3-yl]piperazine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Azanidazole

Experimental
Matched Iupac: … 4-[(E)-2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl]pyrimidin-2-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

Autologous Non-Hematopoietic Peripheral Blood Stem Cells

Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.
Investigational
Matched Description: … The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.[L16363] …

Di-Stearoyl-3-Sn-Phosphatidylethanolamine

Experimental
Matched Name: … Di-Stearoyl-3-Sn-Phosphatidylethanolamine …

N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine

Experimental
Matched Iupac: … (2R,3R)-2-[(2S)-2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanamido]-3-hydroxybutanoic acid …

Glyceraldehyde-3-Phosphate Dehydrogenase

Investigational
Matched Name: … Glyceraldehyde-3-Phosphate Dehydrogenase …
Matched Categories: … Glyceraldehyde-3-Phosphate Dehydrogenases, antagonists & inhibitors …
Displaying drugs 10626 - 10650 of 12370 in total